Business Description
Zenotech Laboratories Ltd
ISIN : INE486F01012
Share Class Description:
BOM:532039: Shs DematerialisedCompare
Compare
Traded in other countries / regions
532039.India IPO Date
1996-10-04Description
Zenotech Laboratories Ltd is an India-based pharmaceutical company. It is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. It also manufactures products such as granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The company earns a vast majority of the revenue from the sale of its contract research and manufacturing services.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.86 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 18.63 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 23.8 | |||||
| 3-Year EBITDA Growth Rate | 39 | |||||
| 3-Year FCF Growth Rate | 109.1 | |||||
| 3-Year Book Growth Rate | 23.2 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 40.19 | |||||
| 9-Day RSI | 36.28 | |||||
| 14-Day RSI | 36.84 | |||||
| 6-1 Month Momentum % | 26.32 | |||||
| 12-1 Month Momentum % | 16.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.41 | |||||
| Quick Ratio | 2.36 | |||||
| Cash Ratio | 1.87 | |||||
| Days Inventory | 60.77 | |||||
| Days Sales Outstanding | 44.55 | |||||
| Days Payable | 165.3 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 87.62 | |||||
| Operating Margin % | 8.13 | |||||
| Net Margin % | 18.67 | |||||
| FCF Margin % | 21.28 | |||||
| ROE % | 7.39 | |||||
| ROA % | 6.28 | |||||
| ROIC % | 2.23 | |||||
| ROC (Joel Greenblatt) % | 14.22 | |||||
| ROCE % | 10.38 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 65.41 | |||||
| PE Ratio without NRI | 75.85 | |||||
| Price-to-Owner-Earnings | 138.57 | |||||
| PEG Ratio | 1.37 | |||||
| PS Ratio | 12.23 | |||||
| PB Ratio | 4.67 | |||||
| Price-to-Tangible-Book | 4.67 | |||||
| Price-to-Free-Cash-Flow | 57.36 | |||||
| Price-to-Operating-Cash-Flow | 36.81 | |||||
| EV-to-EBIT | 43 | |||||
| EV-to-EBITDA | 24.91 | |||||
| EV-to-Revenue | 11.55 | |||||
| EV-to-FCF | 54.62 | |||||
| Price-to-Projected-FCF | 20.14 | |||||
| Price-to-Median-PS-Value | 0.93 | |||||
| Price-to-Peter-Lynch-Fair-Value | 5.35 | |||||
| Price-to-Graham-Number | 3.97 | |||||
| Price-to-Net-Current-Asset-Value | 27.74 | |||||
| Price-to-Net-Cash | 49.51 | |||||
| Earnings Yield (Greenblatt) % | 2.33 | |||||
| FCF Yield % | 1.74 | |||||
| Forward Rate of Return (Yacktman) % | 19.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zenotech Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 356.55 | ||
| EPS (TTM) (₹) | 1.09 | ||
| Beta | 0.65 | ||
| Volatility % | 49.64 | ||
| 14-Day RSI | 36.84 | ||
| 14-Day ATR (₹) | 2.971915 | ||
| 20-Day SMA (₹) | 74.255 | ||
| 12-1 Month Momentum % | 16.14 | ||
| 52-Week Range (₹) | 52.23 - 107.79 | ||
| Shares Outstanding (Mil) | 61.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zenotech Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zenotech Laboratories Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zenotech Laboratories Ltd Frequently Asked Questions
What is Zenotech Laboratories Ltd(BOM:532039)'s stock price today?
The current price of BOM:532039 is ₹71.30. The 52 week high of BOM:532039 is ₹107.79 and 52 week low is ₹52.23.
When is next earnings date of Zenotech Laboratories Ltd(BOM:532039)?
The next earnings date of Zenotech Laboratories Ltd(BOM:532039) is .
Does Zenotech Laboratories Ltd(BOM:532039) pay dividends? If so, how much?
Zenotech Laboratories Ltd(BOM:532039) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers